Cargando…
Prostate cancer treatment costs increase more rapidly than for any other cancer—how to reverse the trend?
According to GLOBOCAN, about 1.41 million new prostate cancer (PCa) cases were registered in the year 2020 globally. The corresponding socio-economic burden is enormous. Anti-cancer mRNA-based therapy is a promising approach, the principle of which is currently applied for anti-COVID-19 vaccination,...
Autores principales: | Ellinger, J., Alajati, A., Kubatka, P., Giordano, F. A., Ritter, M., Costigliola, V., Golubnitschaja, O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886338/ https://www.ncbi.nlm.nih.gov/pubmed/35251382 http://dx.doi.org/10.1007/s13167-022-00276-3 |
Ejemplares similares
-
Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper
por: Golubnitschaja, Olga, et al.
Publicado: (2022) -
Is ostension any more than attention?
por: Szufnarowska, Joanna, et al.
Publicado: (2014) -
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine
por: Kapinova, Andrea, et al.
Publicado: (2023) -
Why Is There So Much More Research on Vision Than on Any Other Sensory Modality?
por: Hutmacher, Fabian
Publicado: (2019) -
Coincidence of cardiovascular disease and breast cancer in females: Multi-modal strategies by predictive, preventive and personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2014)